Fan Zhong

Xuhui Tian, Xinran Lin, Fan Zhong et al.

Optimization-based 3D object tracking is known to be precise and fast, but sensitive to large inter-frame displacements. In this paper we propose a fast and effective non-local 3D tracking method. Based on the observation that erroneous local minimum are mostly due to the out-of-plane rotation, we propose a hybrid approach combining non-local and local optimizations for different parameters, resulting in efficient non-local search in the 6D pose space. In addition, a precomputed robust contour-based tracking method is proposed for the pose optimization. By using long search lines with multiple candidate correspondences, it can adapt to different frame displacements without the need of coarse-to-fine search. After the pre-computation, pose updates can be conducted very fast, enabling the non-local optimization to run in real time. Our method outperforms all previous methods for both small and large displacements. For large displacements, the accuracy is greatly improved ($81.7\% \;\text{v.s.}\; 19.4\%$). At the same time, real-time speed ($>$50fps) can be achieved with only CPU. The source code is available at \url{https://github.com/cvbubbles/nonlocal-3dtracking}.

Xiaoqiong Xia, Chaoyu Zhu, Yuqi Shan et al.

Accurate and robust drug response prediction is of utmost importance in precision medicine. Although many models have been developed to utilize the representations of drugs and cancer cell lines for predicting cancer drug responses (CDR), their performances can be improved by addressing issues such as insufficient data modality, suboptimal fusion algorithms, and poor generalizability for novel drugs or cell lines. We introduce TransCDR, which uses transfer learning to learn drug representations and fuses multi-modality features of drugs and cell lines by a self-attention mechanism, to predict the IC50 values or sensitive states of drugs on cell lines. We are the first to systematically evaluate the generalization of the CDR prediction model to novel (i.e., never-before-seen) compound scaffolds and cell line clusters. TransCDR shows better generalizability than 8 state-of-the-art models. TransCDR outperforms its 5 variants that train drug encoders (i.e., RNN and AttentiveFP) from scratch under various scenarios. The most critical contributors among multiple drug notations and omics profiles are Extended Connectivity Fingerprint and genetic mutation. Additionally, the attention-based fusion module further enhances the predictive performance of TransCDR. TransCDR, trained on the GDSC dataset, demonstrates strong predictive performance on the external testing set CCLE. It is also utilized to predict missing CDRs on GDSC. Moreover, we investigate the biological mechanisms underlying drug response by classifying 7,675 patients from TCGA into drug-sensitive or drug-resistant groups, followed by a Gene Set Enrichment Analysis. TransCDR emerges as a potent tool with significant potential in drug response prediction. The source code and data can be accessed at https://github.com/XiaoqiongXia/TransCDR.

Jiachen Li, Bin Wang, Shiqiang Zhu et al.

Template-based 3D object tracking still lacks a high-precision benchmark of real scenes due to the difficulty of annotating the accurate 3D poses of real moving video objects without using markers. In this paper, we present a multi-view approach to estimate the accurate 3D poses of real moving objects, and then use binocular data to construct a new benchmark for monocular textureless 3D object tracking. The proposed method requires no markers, and the cameras only need to be synchronous, relatively fixed as cross-view and calibrated. Based on our object-centered model, we jointly optimize the object pose by minimizing shape re-projection constraints in all views, which greatly improves the accuracy compared with the single-view approach, and is even more accurate than the depth-based method. Our new benchmark dataset contains 20 textureless objects, 22 scenes, 404 video sequences and 126K images captured in real scenes. The annotation error is guaranteed to be less than 2mm, according to both theoretical analysis and validation experiments. We re-evaluate the state-of-the-art 3D object tracking methods with our dataset, reporting their performance ranking in real scenes. Our BCOT benchmark and code can be found at https://ar3dv.github.io/BCOT-Benchmark/.

Shuangbing Song, Fan Zhong, Tianju Wang et al.

Guided upsampling is an effective approach for accelerating high-resolution image processing. In this paper, we propose a simple yet effective guided upsampling method. Each pixel in the high-resolution image is represented as a linear interpolation of two low-resolution pixels, whose indices and weights are optimized to minimize the upsampling error. The downsampling can be jointly optimized in order to prevent missing small isolated regions. Our method can be derived from the color line model and local color transformations. Compared to previous methods, our method can better preserve detail effects while suppressing artifacts such as bleeding and blurring. It is efficient, easy to implement, and free of sensitive parameters. We evaluate the proposed method with a wide range of image operators, and show its advantages through quantitative and qualitative analysis. We demonstrate the advantages of our method for both interactive image editing and real-time high-resolution video processing. In particular, for interactive editing, the joint optimization can be precomputed, thus allowing for instant feedback without hardware acceleration.

Yang Li, Fan Zhong, Xin Wang et al.

Previous evaluations on 6DoF object pose tracking have presented obvious limitations along with the development of this area. In particular, the evaluation protocols are not unified for different methods, the widely-used YCBV dataset contains significant annotation error, and the error metrics also may be biased. As a result, it is hard to fairly compare the methods, which has became a big obstacle for developing new algorithms. In this paper we contribute a unified benchmark to address the above problems. For more accurate annotation of YCBV, we propose a multi-view multi-object global pose refinement method, which can jointly refine the poses of all objects and view cameras, resulting in sub-pixel sub-millimeter alignment errors. The limitations of previous scoring methods and error metrics are analyzed, based on which we introduce our improved evaluation methods. The unified benchmark takes both YCBV and BCOT as base datasets, which are shown to be complementary in scene categories. In experiments, we validate the precision and reliability of the proposed global pose refinement method with a realistic semi-synthesized dataset particularly for YCBV, and then present the benchmark results unifying learning&non-learning and RGB&RGBD methods, with some finds not discovered in previous studies.

Jichao Zhang, Yezhi Shu, Songhua Xu et al.

Recent Image-to-Image Translation algorithms have achieved significant progress in neural style transfer and image attribute manipulation tasks. However, existing approaches require exhaustively labelling training data, which is labor demanding, difficult to scale up, and hard to migrate into new domains. To overcome such a key limitation, we propose Sparsely Grouped Generative Adversarial Networks (SG-GAN) as a novel approach that can translate images on sparsely grouped datasets where only a few samples for training are labelled. Using a novel one-input multi-output architecture, SG-GAN is well-suited for tackling sparsely grouped learning and multi-task learning. The proposed model can translate images among multiple groups using only a single commonly trained model. To experimentally validate advantages of the new model, we apply the proposed method to tackle a series of attribute manipulation tasks for facial images. Experimental results demonstrate that SG-GAN can generate image translation results of comparable quality with baselines methods on adequately labelled datasets and results of superior quality on sparsely grouped datasets. The official implementation is publicly available:https://github.com/zhangqianhui/Sparsely-Grouped-GAN.

Yuhang Huang, Zekai Lin, Fan Zhong et al.

Explanations for AI models in high-stakes domains like medicine often lack verifiability, which can hinder trust. To address this, we propose an interactive agent that produces explanations through an auditable sequence of actions. The agent learns a policy to strategically seek external visual evidence to support its diagnostic reasoning. This policy is optimized using reinforcement learning, resulting in a model that is both efficient and generalizable. Our experiments show that this action-based reasoning process significantly improves calibrated accuracy, reducing the Brier score by 18\% compared to a non-interactive baseline. To validate the faithfulness of the agent's explanations, we introduce a causal intervention method. By masking the visual evidence the agent chooses to use, we observe a measurable degradation in its performance ($Δ$Brier=+0.029), confirming that the evidence is integral to its decision-making process. Our work provides a practical framework for building AI systems with verifiable and faithful reasoning capabilities.

Zekai Lin, Haoran Sun, Yucheng Guo et al.

Distinguishing pathogenic mutations from benign polymorphisms remains a critical challenge in precision medicine. EnTao-GPM, developed by Fudan University and BioMap, addresses this through three innovations: (1) Cross-species targeted pre-training on disease-relevant mammalian genomes (human, pig, mouse), leveraging evolutionary conservation to enhance interpretation of pathogenic motifs, particularly in non-coding regions; (2) Germline mutation specialization via fine-tuning on ClinVar and HGMD, improving accuracy for both SNVs and non-SNVs; (3) Interpretable clinical framework integrating DNA sequence embeddings with LLM-based statistical explanations to provide actionable insights. Validated against ClinVar, EnTao-GPM demonstrates superior accuracy in mutation classification. It revolutionizes genetic testing by enabling faster, more accurate, and accessible interpretation for clinical diagnostics (e.g., variant assessment, risk identification, personalized treatment) and research, advancing personalized medicine.